
4 Things to Know About the FDA’s Move to Expand Access to Abortion Pills
The U.S. Food and Drug Administration’s new guidance on medication abortion has the potential to increase access to care, though challenges remain.
they/she
Kierra B. Jones is a policy analyst for the Women’s Initiative at American Progress. Prior to joining American Progress, Jones was a research and policy analyst at the Urban Institute, where they supported a range of projects to advance sexual and reproductive health and rights for incarcerated people, programs to support families affected by incarceration, and sex workers’ rights. Jones received a Master of Arts in sociology from the University of South Carolina, where they researched issues related to LGBTQ+ families and HIV prevention and access to care.
The U.S. Food and Drug Administration’s new guidance on medication abortion has the potential to increase access to care, though challenges remain.
This is the first installment in the Center for American Progress’ series highlighting best practices to improve and expand contraceptive access at the state level.
This fact sheet accompanies the Center for American Progress’ report on best practices to expand and improve contraceptive access at the state level, covering common implementation challenges and offering recommendations for one-year contraceptive dispensing policies.
Approving birth control pills to be sold over the counter could expand access to contraceptive options, increase women’s bodily autonomy, and ensure people can decide when to become pregnant.
Approving oral hormonal contraceptive pills to be sold over the counter could expand access to contraceptive options, increase women’s bodily autonomy, and ensure people can decide when to become pregnant.
Abortion is protected by state law in more than 20 states, many of which have expanded access to abortion by making it more affordable, codifying state-level reproductive rights, broadening the types of providers able to offer care, and protecting abortion providers and access to clinics.